About NeuroFine
NeuroFine is a private company based in Miramar, Florida. It has reported $4,390,528 raised in five offerings on Form D since October 2021. Its chief executive is Ajay Wakhloo.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 23, 2026 | Apr 8, 2026 | $1,045,859fully sold | 14 | $74,704 | EquityRule 506(b) | Form D ↗ |
| Aug 19, 2025 | Sep 3, 2025 | $125,000of $5.0M target | 2 | $62,500 | OptionsRule 506(b) | Form D ↗ |
| Mar 5, 2025 | Mar 20, 2025 | $885,970of $2.0M target | 12 | $73,831 | Debt, OptionsRule 506(b) | Form D ↗ |
| Aug 31, 2023 | Sep 13, 2023 | $709,651of $3.9M target | 16 | $44,353 | EquityRule 506(b) | Form D ↗ |
| Sep 29, 2021 | Oct 20, 2021 | $1,624,048of $1.6M target | 38 | $42,738 | EquityRule 506(b) | Form D ↗ |
| Total, five offerings | $4,390,528 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeuroFine's Form D filed Apr 8, 2026.
Ajay Wakhloo
Chief Executive Officer and director
Also a director at Deinde Medical and CEO and director at Prometheus Therapeutics.
JM
DS
Daniel Sablyak
Director
BN
Bernie Navarro
Executive officer
Also an executive officer at Deinde Medical and Prometheus Therapeutics.
ML
Marc Litzenberg
Director
Also a chief executive officer and director at Deinde Medical and an executive officer and director at Prometheus Therapeutics.